ArticleFrontiers in pharmacology2025

Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability.

Jennifer G Gaultney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.